579 related articles for article (PubMed ID: 25862494)
1. Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: A systematic review and meta-analysis of observational studies.
Ungprasert P; Cheungpasitporn W; Crowson CS; Matteson EL
Eur J Intern Med; 2015 May; 26(4):285-91. PubMed ID: 25862494
[TBL] [Abstract][Full Text] [Related]
2. Nonaspirin Nonsteroidal Anti-Inflammatory Drugs and Risk of Hemorrhagic Stroke: A Systematic Review and Meta-Analysis of Observational Studies.
Ungprasert P; Matteson EL; Thongprayoon C
Stroke; 2016 Feb; 47(2):356-64. PubMed ID: 26670086
[TBL] [Abstract][Full Text] [Related]
3. Non-steroidal anti-inflammatory drug-induced cardiovascular adverse events: a meta-analysis.
Gunter BR; Butler KA; Wallace RL; Smith SM; Harirforoosh S
J Clin Pharm Ther; 2017 Feb; 42(1):27-38. PubMed ID: 28019014
[TBL] [Abstract][Full Text] [Related]
4. Selective and non-selective non-steroidal anti-inflammatory drugs and the risk of acute kidney injury.
Lafrance JP; Miller DR
Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):923-31. PubMed ID: 19585463
[TBL] [Abstract][Full Text] [Related]
5. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.
Jaturapatporn D; Isaac MG; McCleery J; Tabet N
Cochrane Database Syst Rev; 2012 Feb; (2):CD006378. PubMed ID: 22336816
[TBL] [Abstract][Full Text] [Related]
6. Non-steroidal anti-inflammatory drugs and risk of heart failure exacerbation: A systematic review and meta-analysis.
Ungprasert P; Srivali N; Kittanamongkolchai W
Eur J Intern Med; 2015 Nov; 26(9):685-90. PubMed ID: 26427540
[TBL] [Abstract][Full Text] [Related]
7. Nonsteroidal Anti-inflammatory Drugs and Risk of Incident Heart Failure: A Systematic Review and Meta-analysis of Observational Studies.
Ungprasert P; Srivali N; Thongprayoon C
Clin Cardiol; 2016 Feb; 39(2):111-8. PubMed ID: 26720629
[TBL] [Abstract][Full Text] [Related]
8. Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile.
Arellano FM; Yood MU; Wentworth CE; Oliveria SA; Rivero E; Verma A; Rothman KJ
Pharmacoepidemiol Drug Saf; 2006 Dec; 15(12):861-72. PubMed ID: 17086563
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.
McGettigan P; Henry D
JAMA; 2006 Oct; 296(13):1633-44. PubMed ID: 16968831
[TBL] [Abstract][Full Text] [Related]
10. Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.
Rahme E; Nedjar H
Rheumatology (Oxford); 2007 Mar; 46(3):435-8. PubMed ID: 17255138
[TBL] [Abstract][Full Text] [Related]
11. Use of non-steroidal anti-inflammatory drugs correlates with the risk of venous thromboembolism in knee osteoarthritis patients: a UK population-based case-control study.
Lee T; Lu N; Felson DT; Choi HK; Dalal DS; Zhang Y; Dubreuil M
Rheumatology (Oxford); 2016 Jun; 55(6):1099-105. PubMed ID: 26983451
[TBL] [Abstract][Full Text] [Related]
12. [Are there any differences in the cardiovascular tolerance between classical NSAIDs and coxibs?].
Valat JP; Deray G; Héloire F
Presse Med; 2006 Sep; 35(9 Spec No 1):1S25-34. PubMed ID: 17078592
[TBL] [Abstract][Full Text] [Related]
13. Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data.
Bally M; Dendukuri N; Rich B; Nadeau L; Helin-Salmivaara A; Garbe E; Brophy JM
BMJ; 2017 May; 357():j1909. PubMed ID: 28487435
[No Abstract] [Full Text] [Related]
14. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials.
Kearney PM; Baigent C; Godwin J; Halls H; Emberson JR; Patrono C
BMJ; 2006 Jun; 332(7553):1302-8. PubMed ID: 16740558
[TBL] [Abstract][Full Text] [Related]
15. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction.
Gislason GH; Jacobsen S; Rasmussen JN; Rasmussen S; Buch P; Friberg J; Schramm TK; Abildstrom SZ; Køber L; Madsen M; Torp-Pedersen C
Circulation; 2006 Jun; 113(25):2906-13. PubMed ID: 16785336
[TBL] [Abstract][Full Text] [Related]
16. The effect of COX-2-selective meloxicam on the myocardial, vascular and renal risks: a systematic review.
Asghar W; Jamali F
Inflammopharmacology; 2015 Feb; 23(1):1-16. PubMed ID: 25515365
[TBL] [Abstract][Full Text] [Related]
17. Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction.
Hernández-Díaz S; Varas-Lorenzo C; García Rodríguez LA
Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):266-74. PubMed ID: 16611201
[TBL] [Abstract][Full Text] [Related]
18. Risk of myocardial infarction associated with selective COX-2 inhibitors: meta-analysis of randomised controlled trials.
Chen LC; Ashcroft DM
Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):762-72. PubMed ID: 17457957
[TBL] [Abstract][Full Text] [Related]
19. Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study.
Arfè A; Scotti L; Varas-Lorenzo C; Nicotra F; Zambon A; Kollhorst B; Schink T; Garbe E; Herings R; Straatman H; Schade R; Villa M; Lucchi S; Valkhoff V; Romio S; Thiessard F; Schuemie M; Pariente A; Sturkenboom M; Corrao G;
BMJ; 2016 Sep; 354():i4857. PubMed ID: 27682515
[TBL] [Abstract][Full Text] [Related]
20. NSAIDs and serious cardiovascular disorders: especially cox-2 inhibitors and diclofenac.
Prescrire Int; 2016 Jan; 25(167):14-6. PubMed ID: 26942254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
